How many patents does
Cancer Research Technology have?
patents
1,749
families
264
granted
373
applications
1,376
US
338
EP
192
WO
161
GB
131
CN
99
JP
89
KR
27
RoW
712
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Cancer Research Technology
Top ten assignees appearing on patents
2009 - 2018
| cancer research technology | 1344 |
| astex therapeutics | 185 |
| astrazeneca | 90 |
| merck patent | 50 |
| pfizer | 45 |
| cyclacel | 28 |
| ignyta | 26 |
| cancer rec tech | 22 |
| vernalis (cambridge) | 21 |
| affitech research | 19 |
Cancer Research Technology
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| tricyclic parp inhibitors | 41 | 2003 |
| 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and gly… 🛈 | 35 | 2003 |
| 1, 3, 4-thiadiazole compounds and their use in treating cancer | 34 | 2014 |
| inhibitor compounds | 34 | 2012 |
| cancer marker and therapeutic target | 34 | 2007 |
| pyrido[2,3-b]pyrazine-8-substituted compounds and their use | 33 | 2007 |
| 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbo… 🛈 | 32 | 2012 |
| 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-i… 🛈 | 28 | 2010 |
| pyrazole derivatives as protein kinase modulators | 28 | 2003 |
| compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-et… 🛈 | 28 | 2007 |